Berlin Cures GmbH   Report issue

For profit Phase 1 Phase 2
Founded: Zug Switzerland (2014)

Organization Overview

First Clinical Trial
2016
NCT02955420
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Berlin Cures GmbH

Active Ingredients

Drugs in Phase 2 Trials (1)

bc 007 (3 trials)

Drugs in Phase 1 Trials (1)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiomyopathies (Phase 2)

Cardiomyopathy, Dilated (Phase 2)

Heart Failure (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2